PERITONITIS BAKTERIAL SPONTAN DAN PENGARUH PENGHAMBAT POMPA PROTON PADA PENDERITIA SIROSIS HATI
Abstract
Abstract.
Spontaneous bacterial peritonitis (SBP) is an acute infection of ascitic fluid in the abdominal cavity (ACAF - ascitic fluid that accumulates in the abdominal cavity) in patients with portal hypertension who experience ascites and is a serious complication of internal medical emergencies in patients with Liver cirrhosis (SH) and nephrotic syndrome (SN). A pathophysiological condition that may be contaminating, such as contamination of dialysate fluid in patients with chronic renal failure (CKD) who receive peritoneal dialysis (PD) or that stimulates the transmission of germs, such as long-term use of proton pump inhibitors (PPI) in SH sufferers, could be an infectious etiology. The pathophysiology of SBP in SH is an inoculation of bacteria in the form of intestinal organisms in ACAF which most likely (> 90%) comes from bacterial contamination due to transmission of germs from the gastrointestinal tract in the presence of enteric microorganism endotoxin which is a direct transmural migration (DTM) of hollow and solid organ bacteria. stomach (gastrointestinal system / esophago-gastro-duodenalis, small and large intestines and pancreatic-hepato-biliary system / pancreas, liver, gallbladder and its ducts); known as enteric bacterial translocation (EBT). Understanding the pathophysiological process of SBP is generally not paid much attention by clinical practitioners, let alone understanding what types of germs are in ascitic fluid. This can be seen from the rare critical assessment (culture and cytology) of the existing ascitic fluid, perhaps even thinking about the presence or absence of ascites at the start of a case of liver cirrhosis (SH). General results show that SH patients who receive PPI therapy appear to experience SBP more often than those who do not receive PPI therapy in their treatment. This review aims to be a critical review of the use of PPIs in liver cirrhosis sufferers to warn of the risk of germ migration from the gastrointestinal tract to ascitic fluid which might cause SBP. Study and understand the literature relating to the management of SBP and the risks of using PPIs in liver cirrhosis sufferers. Gain an understanding of the risks of using PPIs in liver cirrhosis sufferers.
Downloads
References
Lata J, Stiburek O, Kopacova M. Spontaneous bacterial peritonitis: a severe complication of liver cirrhosis.World J Gastroenterol. Nov 28 2009;15(44):5505-10
Khan S, Linganna M. Diagnosis and management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome. Cleveland Clinic Journal of Medicine April 2023, 90 (4) 209-213; DOI: https://doi/10.3949/ccjm.90a.22028
Tariq R, Furqan F, Wahab A. et al. Association of Proton Pum Ihibitors With Spontaneous Bacterial Peritonitis in Patients With Cirrhosis: An Adjusted Meta-Analysis of Observational Studies. 1015. Am J Gastroenterol 113():p S570-S572, October 2018.
Green TE, Kulkarni R. Spontaneous bacterial peritonitis. http://emedicine.medscape.com/article/789105-overview#showall
Cholongitas E, Papatheodoridis GV, Lahanas A, Xanthaki A, Kontou-Kastellanou C, Archimandritis AJ. Increasing frequency of Gram-positive bacteria in spontaneous bacterial peritonitis. Liver Int. Feb 2005;25(1):57-61
Cornelisson CN, Hobss MM, Lippincott Illustrated Reviews: Microbiology, 4Th ed.,Philadelphia: Wolters Kluwer, 2020 p.118
Maimunah U, Kurniawan AA, Palayukan A. Adverse Effects of Long-term Proton Pump Inhibitors in Chronic Liver Disease Patients – A Preliminary Article Review. Review of Clinical Pharmacology and Pharmacokinetics, International Edition, 38(1), 87-97. https://doi.org/10.61873/WWAY6273 Universitas Airlangga. Powered by pure, Scopus & Elsevier Fingerprint Engine. Copyright (c) 2024.
Alhumaid S, Al-Mutair A, Al-Alawi Z. Et al. Proton Pump Inhibitors use risk of developing spontaneous bacterial peritonitis in cirrhotic patients: A Systemic review and meta-analyssis. Gut Pathog 2021; 13: 17. Published online 2021 Mar 19. Doi: 10.1186/s13099-021-00414-8. PMCID: PMC7977161/PMID: 33741033.
Janka, Tamas, Tornai, et al. Deleterious sffect of proton pump inhibitors on the disease course of cirrhosis. European Journal of Gastroenterology & hepatology 32(2):p 257-264, February 2020 / DOI: 10.1097 / MEG.0000000000001499.
Dahabra L, Kreidieh M, Abureesh M, et al. Proton Pump Inhibitors Use and Increased Risk of Spontaneous Bacterial Peritonitis in Cirrhotic Patients: A Retrospective Cohort Analysis. Gastroenterol Res. 2022;15(4):180-187. Doi: https://doi.org/10.14740/gr1545.
Copyright (c) 2024 Medika Alkhairaat: Jurnal Penelitian Kedokteran dan Kesehatan
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Medika Alkhairaat : Jurnal Penelitian Kedokteran dan Kesehatan agree to the following terms:
1. Authors retain copyright and grant Journal Medika Alkhairaat right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/) that allows others to remix, adapt, build upon the work non-commercially with an acknowledgement of the work’s authorship and initial publication in Journal Medika Alkhairaat.
2. Authors are permitted to copy and redistribute the journal’s published version of the work non-commercially (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in Journal Medika Alkhairaat.
